DE3238984A1 - Arzneimittel auf basis von progesteron - Google Patents
Arzneimittel auf basis von progesteronInfo
- Publication number
- DE3238984A1 DE3238984A1 DE19823238984 DE3238984A DE3238984A1 DE 3238984 A1 DE3238984 A1 DE 3238984A1 DE 19823238984 DE19823238984 DE 19823238984 DE 3238984 A DE3238984 A DE 3238984A DE 3238984 A1 DE3238984 A1 DE 3238984A1
- Authority
- DE
- Germany
- Prior art keywords
- progesterone
- group
- medicament according
- mastodynia
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title claims description 38
- 239000000186 progesterone Substances 0.000 title claims description 19
- 229960003387 progesterone Drugs 0.000 title claims description 19
- 239000003814 drug Substances 0.000 title claims description 9
- 229940079593 drug Drugs 0.000 title claims description 4
- 208000006662 Mastodynia Diseases 0.000 claims description 9
- 210000000481 breast Anatomy 0.000 claims description 9
- 206010006298 Breast pain Diseases 0.000 claims description 8
- 208000030270 breast disease Diseases 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010006312 Breast swelling Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 201000004471 adenofibroma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8120034A FR2515041A1 (fr) | 1981-10-26 | 1981-10-26 | Medicament a base de progesterone pour le traitement des affections mammaires |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3238984A1 true DE3238984A1 (de) | 1983-05-05 |
| DE3238984C2 DE3238984C2 (enrdf_load_stackoverflow) | 1991-12-19 |
Family
ID=9263374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19823238984 Granted DE3238984A1 (de) | 1981-10-26 | 1982-10-21 | Arzneimittel auf basis von progesteron |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE3238984A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2515041A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2109231A (enrdf_load_stackoverflow) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997046242A1 (en) * | 1996-06-03 | 1997-12-11 | Bair Glenn O | Natural progesterone for the treatment of side effects of progestins and progesterone analogues |
| WO2000048604A1 (de) * | 1999-02-18 | 2000-08-24 | Jenapharm Gmbh & Co. Kg | Verwendung von dienogest in hoher dosierung |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| WO2005092309A1 (en) * | 2004-03-22 | 2005-10-06 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| ATE279916T1 (de) | 1996-07-22 | 2004-11-15 | Renovo Ltd | Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden |
| US6056972A (en) * | 1997-02-26 | 2000-05-02 | Dimera, Llc | Method for reducing coronary artery reactivity |
| AU2006299833B2 (en) | 2005-10-12 | 2012-04-12 | Besins Healthcare Luxembourg Sarl | Improved testosterone gel and method of use |
| DE102008064534A1 (de) * | 2008-12-29 | 2010-07-15 | Reimers, Simon | Mobil-Aufrecht-Fahr-System |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| EP0020794A1 (en) * | 1979-06-08 | 1981-01-07 | Toko Yakuhin Kogyo Kabushiki Kaisha | Creamy preparation containing steroid and process for the preparation thereof |
| GB1593953A (en) * | 1977-01-31 | 1981-07-22 | American Home Prod | Therapeutic compositions containing gums |
-
1981
- 1981-10-26 FR FR8120034A patent/FR2515041A1/fr active Granted
-
1982
- 1982-10-19 GB GB08229804A patent/GB2109231A/en not_active Withdrawn
- 1982-10-21 DE DE19823238984 patent/DE3238984A1/de active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| GB1593953A (en) * | 1977-01-31 | 1981-07-22 | American Home Prod | Therapeutic compositions containing gums |
| EP0020794A1 (en) * | 1979-06-08 | 1981-01-07 | Toko Yakuhin Kogyo Kabushiki Kaisha | Creamy preparation containing steroid and process for the preparation thereof |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997046242A1 (en) * | 1996-06-03 | 1997-12-11 | Bair Glenn O | Natural progesterone for the treatment of side effects of progestins and progesterone analogues |
| WO2000048604A1 (de) * | 1999-02-18 | 2000-08-24 | Jenapharm Gmbh & Co. Kg | Verwendung von dienogest in hoher dosierung |
| US6670350B1 (en) | 1999-02-18 | 2003-12-30 | Jenapharm Gmbh & Co. Kg | Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| WO2005092309A1 (en) * | 2004-03-22 | 2005-10-06 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US8048927B2 (en) | 2004-03-22 | 2011-11-01 | Besins Healthcare Luxembourg | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2109231A (en) | 1983-06-02 |
| DE3238984C2 (enrdf_load_stackoverflow) | 1991-12-19 |
| FR2515041B3 (enrdf_load_stackoverflow) | 1984-06-15 |
| FR2515041A1 (fr) | 1983-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69122464T2 (de) | Transdermal absorbierbares mittel mit morphin hydrochlorid | |
| DE3872521T3 (de) | Steroide enthaltende flüssigkeit. | |
| DE3238984A1 (de) | Arzneimittel auf basis von progesteron | |
| DE2947742C2 (de) | Arzneimittel, enthaltend β-Cyclodextrin | |
| DE69730214T2 (de) | Zusammensetzung und verfahren zur behandlung von herpes simplex | |
| US4104373A (en) | Therapeutical composition | |
| DE19547317A1 (de) | Antivirales Medikament | |
| DE3443242A1 (de) | Glycyrrhizin und einen wirkstoff enthaltendes arzneimittel | |
| DE1917283C3 (de) | Herstellung antimikrobieller Präparate | |
| Carson et al. | Clinical studies of induction agents XLI: venous sequelae following the use of the steroid anaesthetic agent, Althesin | |
| DE3315463A1 (de) | Arzneimittel zur lokalen behandlung von psoriasis | |
| DE2741599A1 (de) | Mittel zur behandlung von akne vulgaris | |
| DE69424679T2 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes | |
| DE29916014U1 (de) | Pharmazeutische Zusammensetzung, umfassend Eukalyptus- und Orangenöl | |
| DE69000960T2 (de) | Zusammensetzung zur behandlung von pigmentierung. | |
| DD294864A5 (de) | Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie | |
| DE2215499C2 (de) | Diäther des Östradiol | |
| CH644374A5 (en) | Water-soluble hydroxyflavone ethers and medicaments containing them | |
| WO2014184223A1 (de) | Mittel und verfahren zur behandlung von herpes | |
| CN115624520B (zh) | 一种地奥司明乳膏剂和应用 | |
| Wilson et al. | Treatment with Sulphapyridine (M&B 693) of Guinea-pigs infected with Brucella abortus | |
| DE2619756A1 (de) | Pharmazeutische zubereitungen von penicillinverbindungen zum rektalen gebrauch | |
| DE2030932C3 (de) | Arzneimittel zur oralen Behandlung von Oxalatsteinen | |
| US3173836A (en) | Method and compositions for the treatment of cutaneous herpetic infections | |
| DE1617433C (de) | Verfahren zur Herstellung von 5,5 Diphenyl hydantoin Natrium Losungen fur Injektionszwecke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |